Nottingham, United Kingdom

Joseph William Wrigglesworth

This inventor holds 6 USPTO granted patents and 11 published patent applications and 6 EPO patents. Top assignees: Step Pharma S.a.s., Bergenbio Asa. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph William Wrigglesworth. Retrieved from https://idiyas.com/inventor/joseph-william-wrigglesworth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Biography of Joseph William Wrigglesworth

Introduction: Joseph William Wrigglesworth is an accomplished inventor based in Nottingham, GB. He holds a total of five patents, showcasing his innovative contributions to the field of chemistry and pharmaceuticals.

Latest Patents: His latest patents include "Compounds - Compounds of formula (I) and related aspects" and "Aminothiazole compounds as inhibitors of CTPS1 - Compounds of formula (I): (I) and related aspects." These patents reflect his expertise in developing novel compounds with potential therapeutic applications.

Career Highlights: Throughout his career, Wrigglesworth has worked with notable companies such as Step Pharma S.a.s. and Bergenbio Asa. His work in these organizations has significantly advanced research in pharmaceutical compounds.

Collaborations: Wrigglesworth has collaborated with esteemed colleagues, including Andrew Richard Novak and Geraint Jones. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion: Joseph William Wrigglesworth's contributions to the field of invention and his collaborative efforts with industry professionals underscore his impact on the scientific community. His ongoing work continues to inspire advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…